Status: Not yet recruiting
A Study on the Use of Sulpegfilgrastim to Prevent the Incidence of Neutropenia With Infection in Newly Diagnosed Non-transplant Multiple Myeloma Patients
The goal of this study is to observe and evaluate the incidence of infection in newly diagnosed, non-transplanted multiple myeloma patients receiving prophylactic treatment with sulpegfilgrastim (a pegylated recombinant human granulocyte colony-stimulating factor).
Participants needed: 24
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: The First Affiliated Hospital of Soochow UniversityUpdated: Jun 12, 2025
Eligibility criteria
Age ≥ 18 years old，weight > 35 kg，regardless of gender; [+8]
Weight≤35kg； [+7]